Hubbry Logo
David SeguiDavid SeguiMain
Open search
David Segui
Community hub
David Segui
logo
7 pages, 0 posts
0 subscribers
Be the first to start a discussion here.
Be the first to start a discussion here.
David Segui
David Segui
from Wikipedia

David Vincent Segui (/sɪˈɡ/; born July 19, 1966) is an American former professional baseball first baseman. During a 15-year Major League Baseball (MLB) career, Segui played for the Baltimore Orioles, New York Mets, Montreal Expos, Seattle Mariners, Toronto Blue Jays, Texas Rangers, and Cleveland Indians.

Key Information

Segui was born in Kansas City, Kansas, the son of former Major League baseball pitcher Diego Seguí. He played collegiate baseball for Louisiana Tech and Kansas City Kansas Community College.

In 1,456 games over 15 seasons, Segui posted a .291 batting average (1412-for-4847) with 683 runs, 284 doubles, 139 home runs, 684 RBI, 524 bases on balls, .359 on-base percentage and .443 slugging percentage. He recorded a .995 fielding percentage primarily as a first baseman, but also played 100 games at left and right field.

Segui was identified by Jason Grimsley as one of the players who had taken human growth hormone during his major league career (he was one of the players whose name was redacted on Grimsley's document).[1] Unlike others, however, Segui had a doctor's prescription for HGH to counter a deficiency he had been diagnosed with, and had previously admitted to using them.

Segui admitted to using anabolic steroids during his career with the Mets, obtaining them from former clubhouse attendant Kirk Radomski.[2] Segui never had any spikes in his performances or home runs, but says he knows about other ballplayers' usage. He was included in the Mitchell Report, which named people who were found using either HGH, steroids, or some other type of PEDs.

See also

[edit]

References

[edit]
[edit]
Revisions and contributorsEdit on WikipediaRead on Wikipedia
from Grokipedia
David Vincent Segui (born July 19, 1966) is an American former professional baseball first baseman who played in Major League Baseball (MLB) for 15 seasons from 1990 to 2004. The son of MLB pitcher Diego Seguí, he was a switch-hitter who batted .291 lifetime with 1,412 hits, 139 home runs, and 684 RBIs while appearing in 1,317 games for the Baltimore Orioles, Montreal Expos, Seattle Mariners, Cleveland Indians, and San Diego Padres. Segui posted career highs of a .334 batting average, 22 home runs, and 103 RBIs in 2000, split between the Orioles and Indians, marking his most productive offensive year. Drafted by the Orioles in the 18th round out of Louisiana Tech University, he debuted with Baltimore in 1990 and later testified in high-profile proceedings related to MLB's performance-enhancing drug issues, having admitted to personal use of anabolic steroids—sourced from a former Mets clubhouse attendant—and human growth hormone to combat injuries and extend his career.

Early life

Family background and upbringing

David Vincent Segui was born on July 19, 1966, in , to Diego Seguí, a Cuban-born active from 1962 to 1977 across teams including the and , and Emily Sauceda, a Kansas native of Mexican descent whom Diego married in 1964. The family's lifestyle revolved around Diego's career, which included leading the in (2.56) in 1970 and extending into the Mexican League until 1984, prompting seasonal travel to follow his assignments while maintaining a primary residence in . Segui grew up alongside three siblings: an older brother, Diego Jr.; a younger brother, Daniel, who was selected by the in the 47th round of the MLB draft; and a younger sister, Diana, born in 1973. His mother managed the logistics of family travel and household discipline, often leveraging baseball privileges as incentives for the children. Early exposure to came through frequent visits to stadiums where Diego played, fostering Segui's passion for the game from infancy—he carried a glove as a —and shaping his development, including learning to switch-hit at age five from an uncle. Diego emphasized a demanding work ethic, demonstrated through hands-on home projects like manually constructing a backyard fence with railroad ties, which Segui later attributed to his own rigorous preparation habits. A notable childhood highlight occurred in 1975, when nine-year-old Segui won a in a father-son home run hitting contest at during his father's time with the Boston Red Sox. This environment of constant immersion, combined with familial support, propelled Segui toward a similar professional path, though he resisted his father's attempts to train him as a in favor of position-player skills.

Education and amateur baseball career

Segui attended Bishop Ward High School in Kansas City, Kansas, where he played for the Cyclones and earned all-state honors during his junior and senior years from 1983 to 1984. The team won the state championship in 1983. He graduated from the school in 1984, having starred as a multi-sport with a focus on . After high school, Segui spent two years playing baseball at Kansas City Kansas Community College. He then transferred to Louisiana Tech University for his junior year in 1987, competing in the Southland Conference. During that season, he hit a game-winning home run against Lamar University, securing the conference championship for the Bulldogs. Segui also gained experience through summer semipro baseball with the Liberal Bee Jays of Liberal, Kansas. His amateur career culminated in being selected by the Baltimore Orioles in the 18th round (454th overall) of the 1987 Major League Baseball June Amateur Draft out of Louisiana Tech. He signed with the organization on September 15, 1987, scouted by Ray Crone.

Major League Baseball career

Minor league development and debut with the Baltimore Orioles

Segui was selected by the Baltimore Orioles in the 18th round (454th overall) of the 1987 MLB June amateur draft out of Louisiana Tech University and signed with the organization on September 15, 1987. He began his professional career in 1988 at the Single-A level with the Hagerstown Suns, where he batted .268 with 3 home runs and 31 RBI in 60 games. In 1989, Segui advanced within the Orioles' system, splitting time between the Single-A and High-A , compiling a .319 , 11 home runs, and 77 RBI across 210 games total in the minors that year, though his primary output came in 127 games at those levels with a .324 average, 11 homers, 76 RBI, and an organization-leading 33 doubles, earning him the Orioles Player of the Year award.
YearTeam(s)LevelGamesAVGHRRBI
1988Hagerstown SunsA60.268331
1989Hagerstown Suns, Frederick KeysA, A+127*.3241176
1990Rochester Red WingsAAA86.336251
*Primary minor league games contributing to award; totals include brief higher-level exposure. Segui's strong performance continued in 1990 at Triple-A with the , where he hit .336 with 2 s and 51 RBI in 86 games, demonstrating readiness for the major leagues. This rapid progression from in 1988 to Triple-A by 1990 reflected his switch-hitting consistency and contact skills, leading to his MLB debut with on May 8, 1990, at age 23 against the Brewers, in which he went 0-for-3 as a defensive replacement at first base. In his rookie season, Segui appeared in 42 games for , batting .257 with 1 and 14 RBI, splitting time between the majors and Rochester.

Stints with the Montreal Expos and Seattle Mariners

Segui joined the via trade from the on June 8, 1995, in exchange for pitcher Reid Cornelius. In his partial 1995 season with the Expos, he batted .305 with 10 home runs and 57 RBIs over 97 games, earning the National League Player of the Month honors for both June and July while ranking in the top 10 league-wide in and at-bats per . He was voted Expos Player of the Year by local media and signed a two-year, $3.1 million extension that offseason. In 1996, Segui hit a walk-off home run on April 19 and recorded a career-high six RBIs on April 28, but a fractured thumb sidelined him for 36 games starting July 3; the Expos went .500 in his absence and missed the playoffs by two games. He finished the year batting .286 with 11 home runs and 58 RBIs in 115 games. Segui's 1997 campaign marked a career peak, as he batted .307 with 21 home runs—his personal best—and 68 RBIs across 125 games, serving as the team's primary cleanup hitter despite missing three and a half weeks for knee surgery on June 4. He became a free agent on October 28, 1997.
YearTeamGABHBAHRRBIOBPSLG
1995MON97383117.3051057.355.457
1996MON115416119.2861158.375.442
1997MON125459141.3072168.380.505
Segui signed a two-year, $4.75 million free-agent contract with the Seattle Mariners on , 1997. In 1998, he homered from both sides of the plate in the second game of the season and batted .305 with 19 home runs and 84 RBIs in 143 games, leading first basemen with a .999 fielding percentage despite a from a July 10 scuffle with . He underwent knee surgery that offseason. Segui appeared in 90 games for the Mariners in 1999, batting .293 with nine home runs and 39 RBIs before the team traded him to the Blue Jays on July 28 for pitchers Tom Davey and Steve Sinclair.
YearTeamGABHBAHRRBIOBPSLG
1998SEA143522159.3051984.359.487
1999SEA90345101.293939.352.452

Later career with the Cleveland Indians and return to the Orioles

On July 28, 2000, Segui was traded from the Texas Rangers to the Cleveland Indians in exchange for outfielder Ricky Ledée. In 57 games with the Indians, he batted .332 with 8 home runs and 46 RBIs, contributing to a career-high overall season of 150 games, a .334 , 19 home runs, and 103 RBIs across both teams. Notably, in his first game with Cleveland on July 29, Segui hit his fifth career grand slam off New York Yankees pitcher , driving in four runs during a 6-for-6 performance that included a double and a single. Following the 2000 season, Segui became a on October 30 and signed a four-year, $28 million contract with the Orioles on December 21, returning to the team where he had debuted a earlier. In 2001, he appeared in 82 games, batting .301 with 10 s and 46 RBIs, primarily as a and . However, injuries limited his play in subsequent years: 26 games in 2002 (.263 average, 2 s, 16 RBIs), 67 games in 2003 (.263 average, 5 s, 25 RBIs), and just 18 games in 2004 (.339 average, 1 , 7 RBIs) before his on September 8, 2004. These persistent health issues, including back and shoulder problems, curtailed what was intended as a productive stint.

Retirement and career statistics

Segui retired from following the 2004 season, after appearing in 18 games for the Baltimore Orioles, where he batted .339 with 1 and 7 RBIs. His final MLB game occurred on September 8, 2004. Over 15 seasons from 1990 to 2004, spanning 1,306 games with seven teams—primarily as a —Segui accumulated 1,412 hits in 4,878 at-bats for a .290 , 139 , 675 runs batted in, 683 runs scored, 524 walks, and 737 strikeouts, yielding an of .357, of .435, and OPS of .792. His career batting statistics are summarized below:
CategoryGames (G)At Bats (AB)Hits (H)Home Runs (HR)Runs Batted In (RBI)Walks (BB)
Career Totals1,3064,8781,412.290139675524.357.435.792
Segui's defensive record at first base included a .995 over 1,149 , ranking among the top performers with at least 1,000 at the position at the time of his retirement. He never appeared in postseason play despite his longevity.

Playing style and achievements

Switch-hitting proficiency and defensive skills

Segui exhibited proficiency as a switch-hitter, maintaining consistent contact and a high from both sides of the plate throughout his 15-season career, where he batted .291 overall in 1,456 . His ability to adapt to pitch contributed to his effectiveness, as switch-hitters like Segui typically avoid the disadvantage, allowing him to face left-handed pitchers from the right side and right-handers from the left. In 1995 with the , he led National League switch-hitters in while hitting .298 overall, demonstrating balanced performance without significant splits disparity reported in contemporary analyses. Defensively, Segui was regarded as a reliable with agile footwork, strong hands, and sound instincts, attributes honed from extensive childhood training with fungo bats by his mother. He posted a career .995 at first base over 1,053 games, ranking among the top performers historically in that metric for the position. In 1991, his first full major league season, Segui led all Baltimore Orioles position players with a .998 across first base and duties, and he was described by team management as the club's premier defensive entering 1992 . During his 1998 stint with the Mariners, he committed just one error in 99 chances at first base, underscoring his precision in handling routine plays and picks. Segui's left-handed throwing arm further aided his range and quick transfers, though he occasionally shifted to left field to accommodate team needs, where he maintained solid if less distinguished metrics.

Notable performances and team contributions

Segui achieved career highs in (.336) and runs batted in (103) during the 2000 season, split between the Texas Rangers and Cleveland Indians, where he also recorded 42 doubles and a .510 , contributing to offensive production as a and . In 1998 with the Seattle Mariners, he batted .305 with 19 home runs and 84 RBI, while leading in fielding percentage at (.999), providing reliable defense and steady run production for a team that contended in the . Earlier, Segui posted a .307 average with a career-best 21 home runs in 1997 for the , helping anchor the lineup during a season where the team finished second in the . He earned the Expos Player of the Year award in 1995 after batting .309 in limited action across the Expos and , demonstrating plate discipline with career-high walks relative to playing time. Key clutch contributions included a against the on April 19, 1996, and a six-RBI performance at on April 28, 1996, both with the Expos, showcasing his ability to deliver in high-leverage situations. In May 1996, he recorded three four-hit games, bolstering team offense during early-season stretches. Segui's consistent switch-hitting and defensive reliability at first base, including reaching 1,000 career games on , 2000, supported various lineups without All-Star recognition or postseason play.

Personal life

Family relationships

David Segui is the son of former pitcher Seguí and his wife, Emilia "Emily" Sauceda, a native of descent whom married in 1963. Seguí, born in in 1937, pitched for 15 seasons across teams including the Kansas City Athletics, , , and Seattle Mariners, appearing in 478 games with a career 4.01 ERA. Emily Seguí died in 2024, and followed in June 2025 at age 87. Segui has three siblings: brothers Diego Seguí Jr. and Daniel Seguí, and sister Diana Seguí. The family resided in , where Segui was born on December 19, 1966, in Kansas City. From his first , Segui has two children: son , born December 20, 1991, and daughter Haley, born September 1, 1994. His second to Donna Moniz produced two sons, and Brock, prior to their divorce.

Residences and post-baseball ventures

Following his retirement from after the 2004 season, David Segui resided in , where he owned a large undergoing extensive renovations. In June 2020, he listed the property for $4.5 million, featuring amenities such as a and amid the ongoing project. By January 2023, with renovations still incomplete, Segui placed the same home on the market for $6.55 million. No major public business ventures or professional pursuits beyond have been documented for Segui post-retirement, with his activities appearing centered on private family matters and occasional media commentary on baseball-related issues.

Personal admissions of PED use

In June 2006, David Segui publicly admitted to that he had used human growth hormone (HGH) under a doctor's prescription during his playing career. He described the use as legal and medically supervised at the time, emphasizing it was not for enhancement but maintenance. Ahead of the Mitchell Report's release in December 2007, Segui disclosed experimenting with anabolic steroids, stating he had cycled them occasionally rather than regularly. On December 10, 2007, he confirmed to the purchasing shipments of steroids from former New York Mets clubhouse attendant , with use primarily during his 1994–1995 tenure with the Mets. Segui noted, "I played more years where I didn't take anything than years where I did," and attributed his career .291 not to the substances but to natural skill. Segui also admitted to using amphetamines, known as "greenies" in baseball, during his Mets stint, alongside the steroids. In a 2019 interview, he reiterated ongoing testosterone therapy from his playing days, crediting it for sustained energy post-retirement, though he framed earlier uses within the pre-2005 era when steroids were not MLB-banned. These admissions positioned Segui as one of the few players voluntarily forthcoming before formal investigations compelled disclosures.

Involvement in investigations and testimony

Segui cooperated with the Mitchell Commission investigation into performance-enhancing drug use in , voluntarily disclosing in December 2007 that he had purchased shipments of anabolic steroids from clubhouse attendant between 1996 and 1999 and experimented with them during his playing career. His admissions were detailed in the commission's report, released on , 2007, which highlighted Radomski's role as a key supplier to multiple players and noted Segui's proactive approach in providing information ahead of the probe's public findings. In June 2010, Segui testified before a federal grand jury in Washington, D.C., as part of the perjury investigation into Roger Clemens, where he was questioned about Clemens's potential use of performance-enhancing drugs, though Segui stated he lacked direct knowledge of such usage by Clemens. During the 2012 U.S. v. Clemens perjury trial, Segui appeared as a prosecution witness on May 24, testifying to corroborate trainer Brian McNamee's account of injecting Clemens with steroids in August 2001 at the Toronto Blue Jays' clubhouse. Segui recounted a 2001 conversation in which McNamee described retaining used needles—"darts," in baseball slang—from Clemens's injections to reassure his wife about the nature of his work, a detail McNamee had stored as potential evidence. The court barred Segui from referencing his own admitted PED use during testimony to avoid prejudicing the jury. U.S. District Judge Reggie Walton had ordered Segui's appearance over defense objections, citing the need to address allegations of McNamee's bias. Segui also self-identified in June 2006 as one of the redacted player names in a federal tied to pitcher Jason Grimsley's PED supplier investigation, which contributed to the broader Mitchell probe by exposing distribution networks linked to Radomski.

Public commentary on PEDs, MLB policies, and cultural impacts

Segui has publicly criticized Major League Baseball's (MLB) disparate treatment of performance-enhancing drugs (PEDs) compared to "drugs of abuse," arguing that PED users face undue demonization while the latter receive protections under the league's Joint Drug Prevention and Treatment Program. In a 2019 , he highlighted the , noting that players testing positive for anabolic steroids face an 80-game suspension without pay, whereas those using substances like marijuana or opioids may receive treatment-focused interventions rather than equivalent penalties. He stated, "I don't smoke , smoke crack, shoot up , or take any of the street drugs, but because I used steroids, I'm demonized," emphasizing that PEDs enhance athletic performance without the societal harms associated with illicit narcotics. Segui has contended that PED use during baseball's "steroid era" does not invalidate players' accomplishments or diminish the sport's integrity, rejecting simplistic moral judgments. He asserted in 2019 that "this doesn't take away from the game," framing PEDs as tools for recovery and performance optimization rather than cheats that undermine competition. He estimated that, as of that year, approximately 60% of MLB players were using PEDs, drawing parallels to inflated totals and suggesting the league's historical tolerance enabled widespread adoption without addressing root causes like competitive pressures. In commentary on MLB policies, Segui has compared the 2021 crackdown on foreign substances (e.g., on baseballs) to the steroid era, claiming the former has a more "direct effect" on outcomes than , as grip enhancers provide immediate advantages to pitchers without the physiological risks of steroids. He argued that MLB's selective enforcement reflects inconsistent standards, similar to how general managers once overlooked PED use for talent acquisition despite private objections. On cultural impacts, Segui has advocated for a pragmatic reevaluation of PED stigma in , viewing the post-steroid backlash as disproportionate and influenced by public outrage rather than evidence of widespread game-fixing. He maintains that facilitated longer careers amid grueling schedules and injuries—citing his own use for wrist and knee recovery—but warns that cultural taboos ignore how such substances align with broader athletic enhancement trends, potentially stifling honest discourse on player health and league economics. This perspective positions the steroid era not as a failing but as a symptom of MLB's delayed testing , which began leaguewide only in despite a 1991 ban on steroids.

References

Add your contribution
Related Hubs
User Avatar
No comments yet.